BIODESIX, INC. Shares Outstanding (Cover Page)
BIODESIX, INC. (BDSX) had Shares Outstanding (Cover Page) of 10.55 million shares as of 2026-07-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-30: Entity Common Stock, Shares Outstanding 10.55M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 10.11M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 9.86M shares.
- 2025-10-28: Entity Common Stock, Shares Outstanding 7.96M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 10.55M shares 10-Q · filed 2026-08-05 |
| 2026-04-29 | 10.11M shares 10-Q · filed 2026-05-04 |
| 2026-02-20 | 9.86M shares 10-K · filed 2026-02-26 |
| 2025-10-28 | 7.96M shares 10-Q · filed 2025-11-03 |
| 2025-07-31 | 146.63M shares 10-Q · filed 2025-08-07 |
| 2025-05-07 | 146.56M shares 10-Q · filed 2025-05-13 |
| 2025-02-24 | 145.98M shares 10-K · filed 2025-03-03 |
| 2024-10-25 | 145.47M shares 10-Q · filed 2024-11-01 |
| 2024-07-31 | 145.18M shares 10-Q · filed 2024-08-07 |
| 2024-05-01 | 114.69M shares 10-Q · filed 2024-05-08 |
| 2024-02-23 | 96.94M shares 10-K · filed 2024-03-01 |
| 2023-11-01 | 90.48M shares 10-Q · filed 2023-11-07 |
| 2023-08-01 | 78.61M shares 10-Q · filed 2023-08-07 |
| 2023-05-04 | 78.46M shares 10-Q · filed 2023-05-11 |
| 2023-03-02 | 77.97M shares 10-K · filed 2023-03-06 |
| 2022-10-31 | 42.09M shares 10-Q · filed 2022-11-03 |
| 2022-08-01 | 39.98M shares 10-Q · filed 2022-08-04 |
| 2022-05-05 | 39.79M shares 10-Q · filed 2022-05-11 |
| 2022-03-09 | 31.31M shares 10-K · filed 2022-03-14 |
| 2021-11-11 | 27.02M shares 10-Q · filed 2021-11-15 |
| 2021-08-06 | 26.97M shares 10-Q · filed 2021-08-10 |
| 2021-05-07 | 26.86M shares 10-Q · filed 2021-05-11 |
| 2021-03-12 | 26.58M shares 10-K · filed 2021-03-16 |
| 2020-12-08 | 26.54M shares 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |